ADDENDUM-Since this paper was accepted for publication a report of a prospective randomised clinical trial comparing the effects of somatostatin and vasopressin in the control of acute variceal haemorrhage has been published ( In eight pairs the diabetic was shorter, and in the remainder the cotwins were the same height. In those dbetics who were shorter than their cotwins at diagnosis the average period of growth delay before diagnosis was at least 35 weeks; by contrast, the mean duration of symptoms was only six weeks. No cause for the growth delay other than the diabetes was known in any of the twins. These findings show that the onset of insulin dependent diabetes may be a slow process, with delay occurring several months before symptoms appear.
Introduction
Growth is a sensitive indicator of health in childhood. Uncontrolled diabetes retards growth: before the discovery of insulin growth stopped completely in children who developed diabetes.' We have used these observations to determine whether diabetes can be present, as shown by growth delay, before the appearance of symptoms.
Studies of heights at diagnosis in diabetic children have produced conflicting results. In most the diabetics were found to be taller than expected,2-' although some studies showed that their heights were normal8 10 1 or that they were shorter.12-"4 These discrepancies may be due to the difficulty in obtaining exactly matched control groups. When comparing heights the groups must be accurately matched for social class, racial origin, and parental height. The ideal control for a diabetic child is his unaffected identical twin, as twins usually grow at the same rate and to the same final height.", We studied the heights of identical twins discordant for insulin dependent diabetes at the time of diagnosis of the diabetic twin in order (a) to determine whether the diabetic was taller or shorter at diagnosis than his unaffected cotwin and (b), if there was a difference, to estimate how long before diagnosis growth had been affected.
Subjects and methods
We studied identical twins included in the King's College Hospital survey. Monozygosity was established as described."6 A sample of twin pairs discordant for insulin dependent diabetes were separated into two groups-group 1, pairs in whom the diabetic twin was diagnosed during the growth years (under 19); and group 2, pairs in whom the diabetic was diagnosed at age 25 or more-that is, after growth had stopped-who served as a control for observer or apparatus error in height measurement. Pairs with a history of major antecedent illness were excluded (none in group 1, three in group 2). E e| Diabetic /--Growth
Age (years)
Method for conversion of height difference found between identical cotwins at diagnosis into period of growth arrest.
Heights of both cotwins at diagnosis of diabetic twin are plotted on Tanner and Whitehouse growth chart (illustrated schematically). Both twins should be growing along same centile line as illustrated by line labelled "non-diabetic." Diabetic, however, is shorter. We extrapolate back to unaffected twin's centile line to find when growth was arrested. Period would be longer if growth was delayed, not arrested (dashed line).
All the cotwins in group 1 were living together at the time the diabetic was diagnosed.
In group 1 43 pairs were available for study, but in only 16 pairs was the height of both twins recorded at the time of diagnosis of the diabetic. In group 2 17 pairs were available for study; we had the final heights of both cotwins in all these pairs.
Height at diagnosis-The height of both cotwins at the time of diagnosis of the diabetic in group 1 either came from our own records (four pairs) or was provided by their referring physician (12 pairs). Heights were measured to the nearest quarter of an inch (6 mm), and for each pair height was estimated by the same observer on the same occasion. A measuring scale fixed to the wall with a mobile arm was used to make the measurements. Final adult heights were used in group 2, and the information came from our own records in all 17 pairs.
Duration of growth arrest before diagnosis-Identical twins are usually the same height.15 The mean height difference between healthy identical cotwins is less than 2 cm. 15 Thus if a diabetic is appreciably shorter than his unaffected cotwin at the time of diagnosis of diabetes his growth must have been affected some time before. The duration of growth arrest or delay which this height difference represents may be estimated by plotting the heights of both cotwins at the time of diagnosis of the diabetic twin on a Tanner and Whitehouse growth chart (see figure) . The diabetic should be growing along the same (table I) . Eight diabetic twins were shorter than their nondiabetic cotwin, and in the remainder the cotwins were the same height. In the eight diabetics who were shorter at diagnosis the mean difference was 3-4 (SEM 0 62) cm (range 1-3 to 7-1 cm). The mean difference for all 16 twin pairs was 1-7 (0-54) cm. By contrast, in group 2, in which the diabetic was diagnosed over the age of 25, the diabetic was taller than his unaffected cotwin in five pairs, the same height in six, and shorter in six ( Sex-Growth arrest was equally common in boys and girls (see table II ).
Birth weight-Except in pair 5, in twins diagnosed under the age of 19 the mean birth weights of the diabetic and non-diabetic cotwins were similar (2-4 (SEM 0-125) v 2-3 (0-1) kg); in pair 5 the diabetic was lighter (1-3 v 2-8 kg) . Nevertheless, the parents of this pair reported that their heights were similar in early childhood.
Birth order-Among twins diagnosed under 19 the diabetic was born first in three of eight pairs with growth arrest and in four of eight pairs not showing growth arrest.
Discussion
These observations suggest that, contrary to the widely accepted belief, young diabetics are not taller than expected at diagnosis'-9: half of our diabetics were shorter than their unaffected cotwin and the remainder were the same height. This is the first study in which the unaffected identical cotwin of a diabetic child has served as the control and thus the first report in which the diabetic and control have been adequately matched.
For accurate recording of absolute heights a Harpenden Stadiometer should be used. That it was not used in our study does not, we think, invalidate our conclusions, because both cotwins of a pair were measured on the same occasion using the same apparatus; furthermore, we were interested in differences in height not absolute heights. Any error in measurement might have occurred with an equal chance in either twin, which would not lead to bias in the results. The validity of this argument is confirmed by the twin pairs diagnosed over the age of 25, in whom growth had stopped long before the diagnosis of diabetes. In this group the diabetic was as often taller, shorter, or the same height as his unaffected cotwin and the mean difference between cotwins was negligible. Thus our results are unlikely to be due to errors in measurement.
There are many causes of growth retardation. In this study twins with any history of major antecedent illness other than diabetes were excluded and there was no evidence of physical or psychological deprivation in the diabetic twin. Genetic factors were irrelevant, as we were comparing identical twins, and congenital influences were unlikely, as, with one exception, birth weights were similar in cotwins. We therefore believe that the growth delay that we found was related to the diabetes.
Growth delay may be due to the metabolic abnormalities associated with diabetes. Before the discovery of insulin diabetic children stopped growing,' and it is still true that after diagnosis the growth of diabetic children may be reduced.7 ' This is believed to be due to poor diabetic control.17 Alternatively, a common patliogenetic mechanism may independently cause both growth delay and diabetes-for example, antibodies to pancreatic islet,1' thyroid,1' and pituitary20 tissue are found in newly diagnosed insulin dependent diabetics, and these may influence growth. We were unable to determine the mechanism of growth delay.
Growth arrest in this study was related to age at diagnosis; of those diagnosed between 4 and 9 years, only one of five showed growth arrest compared with seven of 11 diagnosed between 10 and 19 years. If this difference was true and not merely due to our small numbers, then the onset of diabetes in the young may be more rapid (and we note that the duration of symptoms was longer, though not significantly so, in those who showed growth delay than in those who did not-6-1 v 3-2 weeks). An alternative explanation is that the difference was due to the age related difference in growth velocity. Growth is rapid in early childhood and during puberty but relatively slow in the intervening years. The more rapid the growth, the more sensitive will it be to any retarding influence.
In those diabetics who were shorter at diagnosis than their unaffected cotwins growth was affected for an average of at least 29 weeks before the appearance of symptoms. If growth had not been arrested but only delayed then this period must have been even greater. We believe that diabetes is more likely to cause growth delay than growth arrest, and this hypothesis is supported by our observations on one twin who showed growth delay with normal glucose tolerance shortly before he developed insulin dependent diabetes. Decrease in growth velocity may be a marker for the future development of diabetes in genetically susceptible subjects.
We believe that this study gives the first definitive evidence for a clinical abnormality preceding the onset of symptoms of diabetes and confirms that insulin dependent diabetes may be a disease of relatively slow onset. '1-28 We thank all the physicians who referred the twins and provided information about them.
